Management of hyperphosphataemia in chronic kidney disease: summary of National Institute for Health and Clinical Excellence (NICE) guideline.

@article{Dasgupta2013ManagementOH,
  title={Management of hyperphosphataemia in chronic kidney disease: summary of National Institute for Health and Clinical Excellence (NICE) guideline.},
  author={Indranil Dasgupta and Rukshana Shroff and David N Bennett-Jones and Gary McVeigh},
  journal={Nephron. Clinical practice},
  year={2013},
  volume={124 1-2},
  pages={1-9}
}
Bone disease and ectopic calcification are the two main consequences of hyperphosphataemia of chronic kidney disease (CKD). Observational studies have demonstrated that hyperphosphataemia in CKD is associated with increased mortality. Furthermore, the use of phosphate binders in dialysis patients is associated with significantly lower mortality. The UK Renal Registry data show significant underachievement of phosphate targets in dialysis patients. It is believed to be due to wide variation in… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 4 times over the past 90 days. VIEW TWEETS
6 Citations
62 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 62 references

; 57 : 804 )

  • W Qunibi, M Moustafa, +4 authors M Budoff
  • Am J Kidney Dis
  • 2011

A randomized , double - blind , placebo - controlled trial of calcium acetate on serum phosphorus concentrations in patients with advanced non - dialysis - dependent chronic kidney disease

  • Sprague, H Abboud, P Qiu, M Dauphin, P Zhang, W Finn
  • BMC Nephrol
  • 2011

rect effects of phosphate on vascular cell function

  • GA Block, PS Klassen, JM Lazarus, N Ofsthun, EG Lowrie, GM Chertow
  • Adv Chronic Kidney Dis
  • 2011

Similar Papers

Loading similar papers…